Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Flow Reserve Changes After Semaglutide Treatment

NCT07190144 is registered in ClinicalTrials.gov with Ekrem Bilal Karaayvaz as lead sponsor.

NCT NCT07190144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Flow Reserve Changes After Semaglutide Treatment
Lead sponsor
Ekrem Bilal Karaayvaz
Phase
Observational
Overall status
Completed
Start date
January 7, 2025
Completion date
August 1, 2025
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight, the study focused on the vascular effects of semaglutide in both diabetic and non-diabetic patients